Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study
Resource Type
Article
Authors
Fisher, Benjamin A ; Szanto, Antonia ; Ng, Wan-Fai ; Bombardieri, Michele ; Posch, Maximilian G ; Papas, Athena S ; Farag, Arwa M ; Daikeler, Thomas ; Bannert, Bettina ; Kyburz, Diego ; Kivitz, Alan J ; Carsons, Steven E ; Isenberg, David A ; Barone, Francesca ; Bowman, Simon J ; Espié, Pascal ; Floch, David ; Dupuy, Cyrielle ; Ren, Xiaohui ; Faerber, Petra M ; Wright, Andrew M ; Hockey, Hans-Ulrich ; Rotte, Michael ; Milojevic, Julie ; Avrameas, Alexandre ; Valentin, Marie-Anne ; Rush, James S ; Gergely, Peter
Source
In The Lancet Rheumatology March 2020 2(3):e142-e152
Subject
Primary Research Articles
Language
ISSN
2665-9913